Taprenepag
Taprenepag (CP-544326) is a potent and selective EP2 prostaglandin receptor agonist with an EC50 of 2.8 nM. It has been investigated in clinical trials for lowering intraocular pressure in ocular hypertension and open-angle glaucoma, supported by both in vitro receptor studies and in vivo pharmacological research.
Product Specifications
CAS Number
752187-80-7
Product Name Alternative
Cells, CP544326, CP-544326, CP 544326, cAMP, inhibit, intraocular, Inhibitor, levels, HEK293, Prostaglandin Receptor, ProstaglandinReceptor, pressure, PGE2, Taprenepag
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.89% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.18 mM) ; DMSO:55 mg/mL (114.94 mM)
Smiles
OC (=O) COc1cccc (CN (Cc2ccc (cc2) -n2cccn2) S (=O) (=O) c2cccnc2) c1
Molecular Formula
C24H22N4O5S
Molecular Weight
478.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
